Rudolf Mueller, Yong-Xin Li, Aidan Hampson, Sheng Zhong, Clayton Harris, Christopher Marrs, Stanislaw Rachwal, Jolanta Ulas, Lena Nielsson, Gary Rogers, Rudolf Mueller, Yong-Xin Li, Aidan Hampson, Sheng Zhong, Clayton Harris, Christopher Marrs, Stanislaw Rachwal, Jolanta Ulas, Lena Nielsson, Gary Rogers
Index: Bioorg. Med. Chem. Lett. 21(13) , 3923-6, (2011)
Full Text: HTML
AMPA receptors (AMPARs) are an increasingly important therapeutic target in the CNS. Aniracetam, the first identified potentiator of AMPARs, led to the rigid and more potent CX614. This lead molecule was optimized in order to increase affinity towards the AMPA receptor. The substitution of the dioxine with a benzoxazinone ring system increased the activity and allowed further investigation of the sidechain SAR.Copyright © 2011 Elsevier Ltd. All rights reserved.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Aniracetam
CAS:72432-10-1 |
C12H13NO3 |
|
Piracetam defines a new binding site for allosteric modulato...
2010-03-11 [J. Med. Chem. 53 , 2197-203, (2010)] |
|
Glutamate Receptors within the Mesolimbic Dopamine System Me...
2015-11-25 [J. Neurosci. 35 , 15523-38, (2015)] |
|
Development and validation of a liquid chromatographic metho...
2011-11-01 [J. Pharm. Biomed. Anal. 56(3) , 615-22, (2011)] |
|
Content determination of aniracetam in aniracetam inclusion ...
2009-01-01 [Artif. Cells Blood Substit. Immobil. Biotechnol. 37(3) , 143-5, (2009)] |
|
Pharmacokinetics and bioequivalence study of aniracetam afte...
2008-01-01 [Arzneimittelforschung 58(10) , 497-500, (2008)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
